Restructuring the Alpha-Gamma Code in Aging Vision
NCT: NCT07208318 · RECRUITING
Brief Summary
Tests whether age-related visual deficits arise from disrupted alpha-gamma coupling in visual cortex (V1) and MT. Uses fMRI, source-resolved HD-EEG, and personalized complex-waveform HD-tACS to (1) quantify aging effects on phase-amplitude coupling, (2) drive PAC into a preferred "gamma-at-alpha-troughs" state, and (3) bidirectionally change perception by aligning gamma to alpha troughs vs peaks. Two five-day, double-blind, sham-controlled studies (n=120 each) target contrast sensitivity (V1) and 3D shape-from-motion (MT), aiming for mechanistic insight and remediation in older adults with implications for ADRD.
Frequently Asked Questions
What is Restructuring the Alpha-Gamma Code in Aging Vision?
Restructuring the Alpha-Gamma Code in Aging Vision is a clinical trial registered under NCT07208318. Current status: RECRUITING.
What is the status of NCT07208318?
The current status of NCT07208318 (Restructuring the Alpha-Gamma Code in Aging Vision) is: RECRUITING.
When did Restructuring the Alpha-Gamma Code in Aging Vision start?
Restructuring the Alpha-Gamma Code in Aging Vision started on 2026-04-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.